About: Pharmacological profiles of exemestane and formestane, steroidal aromatase inhibitors used for treatment of postmenopausal breast cancer

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Pharmacological profiles of exemestane and formestane, steroidal aromatase inhibitors used for treatment of postmenopausal breast cancer Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 1998

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 1998 (uk) im Januar 1998 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 1998 (ast) scientific article published on 01 January 1998 (en) artikull shkencor i botuar më 01 janar 1998 (sq)
publication date	wds:Q77493115-A50CE9B2-4C9D-44D3-8873-DD72B67E023A
publication date	1998-01-01 00:00:00Z (xsd:dateTime)
exact match	wds:Q77493115-CE488DA5-2416-43ED-8E63-248C646250FD
exact match	https://scigraph.springernature.com/pub.10.1023/a:1006048722559
cites work	wds:Q77493115-0616885D-7263-4952-846D-CE0481AA11CC wds:Q77493115-0B7C05EE-1BD8-49D9-AFDB-30ED7D8E9EC1 wds:Q77493115-21F5CCBB-71EE-4FBD-97EA-7BF5ECC748BE wds:Q77493115-241F2BC4-B043-42E3-B41F-0C245C9C81E4 wds:Q77493115-2D749A4F-3845-4B4E-A848-B5AF122A7A5E wds:Q77493115-321E0941-84A3-4B1F-ABA8-C58B7519413F wds:Q77493115-370531DA-4DB5-48FC-BFD3-BBAD873506F8 wds:Q77493115-3E20E7E8-774C-4C58-A4A2-2E5C2A42B683 wds:Q77493115-427EBBA1-41B1-4CF3-ACC9-38C9DE7C482C wds:Q77493115-586C6C93-A8F1-4452-ACAA-53214E88916A wds:Q77493115-5ADAF12E-ECBF-4671-BF26-C79D784FEB61 wds:Q77493115-6EA2F649-3CED-4F6B-A0CD-E10C118F02DD wds:Q77493115-761C9361-352A-436A-BBA5-02205392335B wds:Q77493115-76ED548D-F1C2-44AD-8310-FDB161A237B4 wds:Q77493115-77FEE1E5-AE8E-4824-8544-58BAEEF889B4 wds:Q77493115-830961BE-13F0-44B9-9B8C-7FAF3F2DBDE7 wds:Q77493115-870D6735-9CC1-4170-A3D5-1D5DC00C4CBF wds:Q77493115-87AB9E5D-76E5-4A45-A3A5-1D75C63EEB17 wds:Q77493115-8D897E08-5E66-467A-9A7E-33C907B65681 wds:Q77493115-930F2FE4-C94B-4715-8984-FF64E72FDC9F wds:Q77493115-9FEE80DD-0187-498B-90CC-EDFA163222BB wds:Q77493115-B0EA998D-4B8F-4E2C-B105-84143D5D8E46 wds:Q77493115-B1C9E435-01A4-4576-AB55-39247CFD51B6 wds:Q77493115-C3AD8B96-95DB-41AB-BF7E-1B0556168C03 wds:Q77493115-C47CDC88-7912-4E11-8912-2D4FB43AA9E5 wds:Q77493115-C6A2612D-1FEA-4E12-9F14-ABCF5598106A wds:Q77493115-D8FCEDBE-E3D6-4B33-BD40-66855E2D0DAD wds:Q77493115-DDEE5058-6384-4CF7-9FAE-BA6104B1C6F1 wds:Q77493115-DFED19CD-A96F-40C7-A69A-9724F9838400 wds:Q77493115-E0FD4B5D-A480-4B4B-A8F3-719FD2250A1A wds:Q77493115-EE92916B-EA5A-4BB1-91E0-C19C8BD37555 wds:Q77493115-FE140B88-1EC1-492D-93F2-7591438C1096
cites work	Inhibition of Peripheral Aromatization of Androstenedione to Estrone in Postmenopausal Women with Breast Cancer Using Δ1Testololactone* Androstenedione production and interconversion rates measured in peripheral blood and studies on the possible site of its conversion to testosterone Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer Importance of estrogen sulfates in breast cancer In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway The Effect of an Aromatase Inhibitor, 4-Hydroxy-4-Androstene- 3,17-Dione, On Estrogen-Dependent Processes in Reproduction and Breast Cancer11 Metabolism of the aromatase inhibitor 4-hydroxyandrostenedione in vivo. Identification of the glucuronide as a major urinary metabolite in patients and biliary metabolite in the rat. Determination of 4-hydroxyandrost-4-ene-3,17-dione metabolism in breast cancer patients using high-performance liquid chromatography-mass spectrometry Concentrations of oestrone and 4-hydroxyandrostenedione in malignant and normal breast tissues Comparison of the pharmacokinetics and pharmacodynamics of unformulated and formulated 4-hydroxyandrostenedione taken orally by healthy men The effects of oral 4-hydroxyandrostenedione on peripheral aromatisation in post-menopausal breast cancer patients Novel aromatase and 5 alpha-reductase inhibitors Endocrinological and clinical evaluation of exemestane, a new steroidal aromatase inhibitor. Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on aminoglutethimide: a phase II multicentre multinational study. Exemestane Study Group Alterations in the production rate and the metabolism of oestrone and oestrone sulphate in breast cancer patients treated with aminoglutethimide Suppression of residual oestrogen production with aminoglutethimide in women following surgical hypophysectomy or adrenalectomy. The influence of intramuscular 4-hydroxyandrostenedione on peripheral aromatisation in breast cancer patients Aromatase inhibition with 4-OHAndrostenedione after prior aromatase inhibition with aminoglutethimide in women with advanced breast cancer Treatment with formestane alone and in combination with aminoglutethimide in heavily pretreated breast cancer patients: clinical and endocrine effects Mechanisms of action of endocrine treatment in breast cancer Effects of Fadrozole (CGS 16949A) and Letrozole (CGS 20267) on the inhibition of aromatase activity in breast cancer patients Postmenopausal estrogen synthesis and metabolism: alterations caused by aromatase inhibitors used for the treatment of breast cancer An endocrine and pharmacokinetic study of four oral doses of formestane in postmenopausal breast cancer patients Epidemiology of non-Hodgkin's lymphoma: recent findings regarding an emerging epidemic. Influence of aminoglutethimide on plasma levels of estrone sulphate and dehydroepiandrosterone sulphate in postmenopausal breast cancer patients Novel irreversible aromatase inhibitors Endocrinological and clinical evaluation of two doses of formestane in advanced breast cancer Aromatase inhibition with 4-hydroxyandrostenedione in the treatment of postmenopausal patients with advanced breast cancer: a phase II study Analysis of the aromatase cytochrome P450 gene in human breast cancers Plasma and urinary oestrogens in breast cancer patients on treatment with 4-hydroxyandrostenedione Aromatase inhibitors and their potential clinical significance A dose response evaluation of delta-1-testololactone in advanced breast cancer.
rdfs:label	Pharmacological profiles of exemestane and formestane, steroidal aromatase inhibitors used for treatment of postmenopausal breast cancer (en) Pharmacological profiles of exemestane and formestane, steroidal aromatase inhibitors used for treatment of postmenopausal breast cancer (nl) Pharmacological profiles of exemestane and formestane, steroidal aromatase inhibitors used for treatment of postmenopausal breast cancer (sq)
skos:prefLabel	Pharmacological profiles of exemestane and formestane, steroidal aromatase inhibitors used for treatment of postmenopausal breast cancer (en) Pharmacological profiles of exemestane and formestane, steroidal aromatase inhibitors used for treatment of postmenopausal breast cancer (nl) Pharmacological profiles of exemestane and formestane, steroidal aromatase inhibitors used for treatment of postmenopausal breast cancer (sq)
name	Pharmacological profiles of exemestane and formestane, steroidal aromatase inhibitors used for treatment of postmenopausal breast cancer (en) Pharmacological profiles of exemestane and formestane, steroidal aromatase inhibitors used for treatment of postmenopausal breast cancer (nl) Pharmacological profiles of exemestane and formestane, steroidal aromatase inhibitors used for treatment of postmenopausal breast cancer (sq)
author	wds:Q77493115-549B1447-503B-4478-9DE3-1BB33D219EBB
author	Per Eystein Lønning
title	wds:Q77493115-2871F06B-EFFA-449F-B418-586DBEFFD230
title	Pharmacological profiles of exemestane and formestane, steroidal aromatase inhibitors used for treatment of postmenopausal breast cancer (en)
page(s)	wds:Q77493115-096ECA99-5A92-4B09-BA36-94B056F52E56
page(s)	S45-52; discussion S73-7
instance of	wds:Q77493115-55b08c64-37c8-40be-abfa-9ec242c50b41 wds:Q77493115-CA45CE7B-3EA9-40FF-B236-A0AD6D4F59CD
instance of	review article scholarly article
main subject	wds:Q77493115-F5F42361-FA05-47AA-9F12-8B3A5749F409
main subject	breast cancer
PubMed ID	wds:Q77493115-2DA21923-371A-4714-976D-CD525BC17821
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9797017
PubMed ID	9797017
published in	wds:Q77493115-954FED26-FF0A-42EE-9A57-72FC11B4076E

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 194 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software